|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/65 | |
| A61K 38/27 | |||
| A61K 38/30 | |||
| A61P 5/06 |
| (11) | Number of the document | 1901770 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06784529.7 |
| Date of filing the European patent application | 2006-06-01 | |
| (97) | Date of publication of the European application | 2008-03-26 |
| (45) | Date of publication and mention of the grant of the patent | 2014-12-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2006/021282 |
| Date | 2006-06-01 |
| (87) | Number | WO 2006/130769 |
| Date | 2006-12-07 |
| (30) | Number | Date | Country code |
| 687617 P | 2005-06-02 | US |
| (72) |
CLARK, Ross G., NZ
|
| (73) |
Ipsen Biopharmaceuticals, Inc.,
106 Allen Road, 3rd Floor, Basking Ridge, NJ 07920,
US
|
| (54) | GH AND IGF-1 FOR TREATMENT OF GROWTH DISORDERS |
| GH AND IGF-1 FOR TREATMENT OF GROWTH DISORDERS |